| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Vascular Biology Center, Department of Physiology, Medical College of Georgia, Augusta, Georgia 30912; and Departments of 2 Medicine (Nephrology) and Molecular Biology and Biophysics and of 3 Medicine (Nephrology) and Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232
The present studies were performed
to determine the contribution of EP2 receptors to renal
hemodynamics by examining afferent arteriolar responses to
PGE2, butaprost, sulprostone, and endothelin-1 in
EP2 receptor-deficient male mice (EP2
/).
Afferent arteriolar diameters averaged 17.8 ± 0.8 µm in
wild-type (EP2+/+) mice and 16.7 ± 0.7 µm in
EP2/ mice at a renal perfusion pressure of 100 mmHg.
Vessels from both groups of mice responded to norepinephrine (0.5 µM)
with similar 17-19% decreases in diameter. Diameters of
norepinephrine-preconstricted afferent arterioles increased by 7 ± 2 and 20 ± 6% in EP2+/+ mice in response to 1 µM PGE2 and 1 µM butaprost, respectively. In contrast,
afferent arteriolar diameter of EP2/ mice decreased by
13 ± 3 and 16 ± 6% in response to PGE2 and
butaprost. The afferent arteriolar vasoconstriction to butaprost in
EP2/ mice was eliminated by angiotensin-converting enzyme inhibition. Sulprostone, an EP1 and EP3
receptor ligand, decreased afferent arteriolar diameter in both groups;
however, the vasoconstriction in the EP2/ mice was
greater than in the EP2+/+ mice. Endothelin-1-mediated
afferent arteriolar diameter responses were enhanced in
EP2/ mice. Afferent arteriolar diameter decreased by
29 ± 7% in EP2/ and 12 ± 7% in
EP2+/+ mice after administration of 1 nM endothelin-1.
These results demonstrate that the EP2 receptor mediates a
portion of the PGE2 afferent arteriolar vasodilation and
buffers the renal vasoconstrictor responses elicited by EP1
and EP3 receptor activation as well as endothelin-1.
prostaglandins; endothelin; kidney; microcirculation
This article has been cited by other articles:
|
|
 |
|
  B. Ponnuchamy and R. A. Khalil Cellular mediators of renal vascular dysfunction in hypertension Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R1001 - R1018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Badzynska and J. Sadowski Opposed effects of prostaglandin E2 on perfusion of rat renal cortex and medulla: interactions with the renin-angiotensin system Exp Physiol, December 1, 2008; 93(12): 1292 - 1302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hultstrom, E. Y. Lai, Z. Ma, O. Kallskog, A. Patzak, and A. E. G. Persson Adenosine triphosphate increases the reactivity of the afferent arteriole to low concentrations of norepinephrine Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2225 - R2231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. F. van Rodijnen, I. J. Korstjens, N. Legerstee, P. M. ter Wee, and G.-J. Tangelder Direct vasoconstrictor effect of prostaglandin E2 on renal interlobular arteries: role of the EP3 receptor Am J Physiol Renal Physiol, March 1, 2007; 292(3): F1094 - F1101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. G. Friis, J. Stubbe, T. R. Uhrenholt, P. Svenningsen, R. M. Nusing, O. Skott, and B. L. Jensen Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells Am J Physiol Renal Physiol, November 1, 2005; 289(5): F989 - F997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Schweda, J. Klar, S. Narumiya, R. M. Nusing, and A. Kurtz Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys Am J Physiol Renal Physiol, September 1, 2004; 287(3): F427 - F433. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
